【摘要】 目的探讨肾癌保留肾单位手术的临床价值和疗效。方法回顾性分析10例行保留肾单位手术的肾癌患者临床资料,其中单侧9例、双侧1例。绝对指征1例,相对指征3例,选择性指征6例。肿瘤直径1.8-4.5cm,均为T1期(1997年TNM标准);行改良肾肿瘤剜除术(切缘于肾肿瘤外1cm正常肾实质处)7例,肾上极切除术1例,肾下极切除术2例。结果10例患者随访4-60个月,平均30个月,未见并发症及残肾肿瘤复发,无瘤生存率与根治性手术者相近。结论肾癌保留肾单位手术安全、有效,适合于对侧肾功能正常、一侧局限且较小的肾肿瘤患者。更多还原

【Abstract】 Objective To evaluate the role of nephron sparing surgery in patients with renal cell carcinoma.Methods A total of 10 patients with renal cell carcinoma treated with nephron sparing surgery was analyzed between July 2000 and July 2005.Among these patients,1 case was bilateral tumor,9 cases were unifocal tumor.1 case was in imperative indications,3 cases in relative indications,and 6 cases in elective indications.The tumor diameter ranged from 1.8cm to 4.5cm,all tumor were in T₁（1997 TNM staging system）.7 cases underwent tumor enucleation at 1 cm apart from surgical margin,1 case underwent upper polar nephrectomy,2 cases underwent lower polar nephrectomy.Results The patients were follwed up for an average period of 30 months（range,3 to 60 months）,no surgical complication or local recurrence has been observed,and its long-term cancer-free survival was comparable to that after radical nephrectomy.Conclusion Nephron sparing surgery is safe and effective for the treatment of renal cell carcinoma and indicated for patients with small,localized tumors and a normal contra-lateral kidney.更多还原